ANAGENICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.007 AUD | 0.00% |
|
0.00% | -63.16% |
| 24/05 | Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics | MT |
| 08/03 | Anagenics Appoints CEO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Personal Products
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.13M | - | - | - | - | - | |
| 394B | ||||||
| 140B | ||||||
| 77.03B | ||||||
| 43.2B | ||||||
| 35.21B |
- Stock Market
- Equities
- AN1 Stock
- Charts Anagenics Limited
- Sector Chart
